TUMOREND
Live / Allowed — Notice of allowance issued (as of 04 Nov 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 10 Mar 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99076128
- Mark type
- Stylized text
- Filed
- 10 Mar 2025
- Published for opposition
- 09 Sept 2025
Goods and services
- Class 005 — Pharmaceuticals: Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment and prevention of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; Pharmaceutical preparations for the treatment of tumors, burns, spinal cord injury; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for wounds
Owner
- Tumorend, LLC, Baton Rouge, LA, US
- Tumorend, LLC, Baton Rouge, LA, US
Prosecution history
- 04 Nov 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 09 Sept 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Sept 2025 — PUBLISHED FOR OPPOSITION
- 03 Sept 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Aug 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 Aug 2025 — ASSIGNED TO EXAMINER
- 10 Mar 2025 — APPLICATION FILING RECEIPT MAILED
- 10 Mar 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 10 Mar 2025 — NEW APPLICATION ENTERED